You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 6,201,105


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,201,105
Title: Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
Abstract:Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s): Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Application Number:09/233,461
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,201,105
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 6,201,105

Introduction

Understanding the intricacies of a patent, particularly one like United States Patent 6,201,105, involves a deep dive into its claims, the patent landscape, and the tools and methodologies used in patent analysis. This article will provide a comprehensive and critical analysis of these aspects.

Understanding the Patent

United States Patent 6,201,105, though not specifically detailed here, represents a typical case where thorough analysis is crucial. Here’s how one would approach such an analysis:

Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention. The claims in a patent like 6,201,105 would be scrutinized for their clarity, breadth, and compliance with patent laws. For instance, the USPTO emphasizes the importance of clear and definite claims, especially under section 112(f) of the Patent Act, which limits the breadth of functional claims to the corresponding structure and its equivalents as disclosed in the specification[3].

Patent Claims Analysis

Claim Scope and Clarity

The scope and clarity of claims are critical for determining the patent's validity and enforceability. Tools like the Patent Claims Research Dataset provided by the USPTO can help in analyzing claim-level statistics and document-level statistics, including measures of patent scope[2].

Claim Dependency and Structure

Understanding the dependency relationship between claims is essential. This can be achieved through datasets that parse claims text and identify individual claims as well as their dependency relationships[2].

Patent Landscape Analysis

Global Dossier and Patent Families

To understand the broader patent landscape, tools like the Global Dossier service offered by the USPTO are invaluable. This service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices, and provides access to the patent family for a specific application[5].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, enabling a comprehensive view of the patent landscape on a single page[5].

Tools and Methodologies for Patent Analysis

LexisNexis PatentAdvisor

Tools like LexisNexis PatentAdvisor provide comprehensive patent analysis. This software offers immediate access to examiner and art unit statistics, helping to predict prosecution outcomes and identify favorable tech center groups. Features like the Examiner Lottery Framework and Examiner Time Allocation (ETA) help in tailoring the prosecution strategy to the assigned examiner's behavior[1].

Advanced Patent Searching Techniques

Advanced searching techniques are crucial for navigating the complexities of multi-jurisdiction filing, claims variation, and scientific sophistication of innovations. Resources like the USPTO's Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer trained staff and local search resources to assist in these efforts[5].

Predicting Prosecution Outcomes

Examiner Statistics and Behavior

Predicting the behavior of the assigned examiner is key to successful patent prosecution. Tools like PatentAdvisor's ETA help in understanding how efficient or inefficient an examiner works, allowing for a tailored prosecution strategy[1].

Appeal Strategies

Access to historical ex parte appeals information, such as that provided by LexisNexis, can help in identifying winning arguments and reducing prosecution time. This data-driven approach can lead to higher quality patents[1].

Licensing Opportunities and Risk Management

Examiner Rejection Analysis

Analyzing examiner rejection data can help in identifying licensing opportunities, infringement risks, and ways to maximize portfolio value. Tools like PatentAdvisor's Examiner Rejection Analysis provide insights derived from years of rejection data to strengthen negotiating positions and protect intellectual property efficiently[1].

Case Studies and Best Practices

Software-Related Patents

Case studies, such as those focusing on software-related patents, highlight the importance of consistent and correct application of patent laws, particularly section 112(f). These studies emphasize the need for transparency and data collection in the examination process to improve the quality of patents[3].

Key Takeaways

  • Clear and Definite Claims: Ensuring claims are clear and definite is crucial for patent validity and enforceability.
  • Comprehensive Analysis Tools: Utilizing tools like LexisNexis PatentAdvisor and the USPTO's Global Dossier service is essential for a thorough patent landscape analysis.
  • Examiner Behavior: Predicting examiner behavior can significantly impact prosecution outcomes.
  • Data-Driven Strategies: Leveraging historical data and analytics can lead to more efficient and successful patent prosecution.
  • Transparency and Training: Ensuring examiners are well-trained and that the examination process is transparent is vital for improving patent quality.

FAQs

  1. What is the importance of section 112(f) in patent claims? Section 112(f) of the Patent Act limits the breadth of functional claims to the corresponding structure and its equivalents as disclosed in the specification, providing clear notice of claim boundaries to the public and preventing overbroad claims[3].

  2. How can tools like LexisNexis PatentAdvisor help in patent prosecution? LexisNexis PatentAdvisor provides access to examiner and art unit statistics, helps predict prosecution outcomes, and identifies favorable tech center groups, allowing for a tailored prosecution strategy[1].

  3. What is the Global Dossier service offered by the USPTO? The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices, and offers tools like Office Action Indicators and Collections View[5].

  4. How can advanced patent searching techniques improve patent insights? Advanced searching techniques help navigate complexities such as multi-jurisdiction filing, claims variation, and scientific sophistication, enabling more informed decisions about licensing, challenging validity, and resource allocation[4].

  5. Why is transparency in the examination process important? Transparency in the examination process, including coding the statutory basis for every rejection, is crucial for evaluating the application of provisions like section 112(f) and improving the quality of patents[3].

Sources

  1. LexisNexis Intellectual Property Solutions. PatentAdvisor | LexisNexis Intellectual Property Solutions.
  2. USPTO. Patent Claims Research Dataset - USPTO.
  3. USPTO. Case Studies - USPTO.
  4. CAS.org. Advanced patent searching techniques - CAS.org.
  5. USPTO. Search for patents - USPTO.

More… ↓

⤷  Subscribe

Details for Patent 6,201,105

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 6,201,105 2009-09-05
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 6,201,105 2009-09-05
Immunex Corporation ENBREL etanercept Injection 103795 September 27, 2004 6,201,105 2009-09-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.